Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Some current issues relating to rubella vaccine.

S R Preblud

    JAMA
    |July 12, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Rubella vaccines are safe and effective for children. Continued vaccination efforts, especially for women, are crucial to prevent congenital rubella syndrome.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A measles outbreak at a college with a prematriculation immunization requirement.

    American journal of public health·1991
    Same author

    Measles among the Amish: a comparative study of measles severity in primary and secondary cases in households.

    The Journal of infectious diseases·1991
    Same author

    Measles antibody: reevaluation of protective titers.

    The Journal of infectious diseases·1990
    Same author

    A school-based measles outbreak: the effect of a selective revaccination policy and risk factors for vaccine failure.

    American journal of epidemiology·1990
    Same author

    Duration of live measles vaccine-induced immunity.

    The Pediatric infectious disease journal·1990
    Same author

    Evidence against increasing rubella seronegativity among adolescent girls.

    American journal of public health·1990
    Same journal

    WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

    JAMA·2026
    Same journal

    FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

    JAMA·2026
    Same journal

    HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

    JAMA·2026
    Same journal

    US Dietary Supplement Use Increasing, Especially in Older Adults.

    JAMA·2026
    Same journal

    Heat Stress From Climate Change Surges Globally.

    JAMA·2026
    Same journal

    Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

    JAMA·2026
    See all related articles

    Area of Science:

    • Immunology
    • Vaccinology
    • Public Health

    Background:

    • Rubella vaccines were licensed in 1969, deemed safe, noncommunicable, and effective.
    • Initial recommendations advised caution for vaccinating women of childbearing age due to potential fetal risks.
    • Accumulated data over 15 years necessitate an update on vaccine safety and efficacy.

    Purpose of the Study:

    • To provide an updated assessment of rubella vaccine data.
    • To evaluate joint symptoms, immunity duration, antibody protection, and fetal risks associated with rubella vaccination.
    • To inform public health strategies for rubella elimination.

    Main Methods:

    • Review of accumulated data over the past 15 years.
    • Analysis of vaccine-induced joint symptoms and revaccination effects.

    Related Experiment Videos

  • Assessment of vaccine-induced immunity duration and antibody levels.
  • Evaluation of fetal risks following maternal rubella vaccination.

    • Main Results:

    • Data confirm the safety and efficacy of rubella vaccines.
    • Understanding of joint symptoms and their management has improved.
    • Vaccine-induced immunity is durable, with low antibody levels offering protection.
    • Risks to the fetus from maternal vaccination are minimal and outweighed by benefits.

    Conclusions:

    • Continued vaccination of all young children is supported.
    • Increased vaccination efforts for susceptible adolescents and young adults, particularly women, are recommended.
    • Enhanced vaccination of women is key to accelerating the elimination of congenital rubella syndrome.